Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Corrigendum to "The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux" [Biochem. Pharmacol. 120 (2016) 46-55].

Sealover NR, Felts B, Kuntz CP, Jarrard RE, Hockerman GH, Lamb PW, Barker EL, Henry LK.

Biochem Pharmacol. 2018 Jan;147:9. doi: 10.1016/j.bcp.2017.11.001. Epub 2017 Nov 28. No abstract available.

PMID:
29195124
2.

Myocutaneous Gracilis Free Flaps in Microsurgical Breast Reconstruction: A Systematic Review Comparing Variations of the Upper Gracilis Flap.

Kang V, Robinson EC, Barker EL, Antony AK.

J Reconstr Microsurg. 2017 Nov;33(9):630-635. doi: 10.1055/s-0037-1604439. Epub 2017 Aug 25. No abstract available.

PMID:
28841736
3.

The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.

Sealover NR, Felts B, Kuntz CP, Jarrard RE, Hockerman GH, Lamb PW, Barker EL, Henry LK.

Biochem Pharmacol. 2016 Nov 15;120:46-55. doi: 10.1016/j.bcp.2016.09.006. Epub 2016 Sep 13. Erratum in: Biochem Pharmacol. 2017 Nov 28;147:9.

PMID:
27638414
4.

Assessing cholesterol storage in live cells and C. elegans by stimulated Raman scattering imaging of phenyl-Diyne cholesterol.

Lee HJ, Zhang W, Zhang D, Yang Y, Liu B, Barker EL, Buhman KK, Slipchenko LV, Dai M, Cheng JX.

Sci Rep. 2015 Jan 22;5:7930. doi: 10.1038/srep07930.

5.

The Concise Guide to PHARMACOLOGY 2013/14: overview.

Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators, Abul-Hasn N, Anderson CM, Anderson CM, Araiksinen MS, Arita M, Arthofer E, Barker EL, Barratt C, Barnes NM, Bathgate R, Beart PM, Belelli D, Bennett AJ, Birdsall NJ, Boison D, Bonner TI, Brailsford L, Bröer S, Brown P, Calo G, Carter WG, Catterall WA, Chan SL, Chao MV, Chiang N, Christopoulos A, Chun JJ, Cidlowski J, Clapham DE, Cockcroft S, Connor MA, Cox HM, Cuthbert A, Dautzenberg FM, Davenport AP, Dawson PA, Dent G, Dijksterhuis JP, Dollery CT, Dolphin AC, Donowitz M, Dubocovich ML, Eiden L, Eidne K, Evans BA, Fabbro D, Fahlke C, Farndale R, Fitzgerald GA, Fong TM, Fowler CJ, Fry JR, Funk CD, Futerman AH, Ganapathy V, Gaisnier B, Gershengorn MA, Goldin A, Goldman ID, Gundlach AL, Hagenbuch B, Hales TG, Hammond JR, Hamon M, Hancox JC, Hauger RL, Hay DL, Hobbs AJ, Hollenberg MD, Holliday ND, Hoyer D, Hynes NA, Inui KI, Ishii S, Jacobson KA, Jarvis GE, Jarvis MF, Jensen R, Jones CE, Jones RL, Kaibuchi K, Kanai Y, Kennedy C, Kerr ID, Khan AA, Klienz MJ, Kukkonen JP, Lapoint JY, Leurs R, Lingueglia E, Lippiat J, Lolait SJ, Lummis SC, Lynch JW, MacEwan D, Maguire JJ, Marshall IL, May JM, McArdle CA, McGrath JC, Michel MC, Millar NS, Miller LJ, Mitolo V, Monk PN, Moore PK, Moorhouse AJ, Mouillac B, Murphy PM, Neubig RR, Neumaier J, Niesler B, Obaidat A, Offermanns S, Ohlstein E, Panaro MA, Parsons S, Pwrtwee RG, Petersen J, Pin JP, Poyner DR, Prigent S, Prossnitz ER, Pyne NJ, Pyne S, Quigley JG, Ramachandran R, Richelson EL, Roberts RE, Roskoski R, Ross RA, Roth M, Rudnick G, Ryan RM, Said SI, Schild L, Sanger GJ, Scholich K, Schousboe A, Schulte G, Schulz S, Serhan CN, Sexton PM, Sibley DR, Siegel JM, Singh G, Sitsapesan R, Smart TG, Smith DM, Soga T, Stahl A, Stewart G, Stoddart LA, Summers RJ, Thorens B, Thwaites DT, Toll L, Traynor JR, Usdin TB, Vandenberg RJ, Villalon C, Vore M, Waldman SA, Ward DT, Willars GB, Wonnacott SJ, Wright E, Ye RD, Yonezawa A, Zimmermann M.

Br J Pharmacol. 2013 Dec;170(8):1449-58. doi: 10.1111/bph.12444.

6.

4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of anandamide analogs.

Zohrabi-Kalantari V, Jarrahian A, Bissantz C, Bergstrom DE, Barker EL, Link A.

Med Chem. 2013 Sep;9(6):881-8.

PMID:
23157226
7.

Systems-scale analysis reveals pathways involved in cellular response to methamphetamine.

Sun L, Li HM, Seufferheld MJ, Walters KR Jr, Margam VM, Jannasch A, Diaz N, Riley CP, Sun W, Li YF, Muir WM, Xie J, Wu J, Zhang F, Chen JY, Barker EL, Adamec J, Pittendrigh BR.

PLoS One. 2011 Apr 20;6(4):e18215. doi: 10.1371/journal.pone.0018215.

8.

Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference.

Powers MS, Barrenha GD, Mlinac NS, Barker EL, Chester JA.

Psychopharmacology (Berl). 2010 Dec;212(4):571-83. doi: 10.1007/s00213-010-1997-2. Epub 2010 Sep 14.

9.

Conformational flexibility of transmembrane helix VII of the human serotonin transporter impacts ion dependence and transport.

Wenthur CJ, Rodríguez GJ, Kuntz CP, Barker EL.

Biochem Pharmacol. 2010 Nov 1;80(9):1418-26. doi: 10.1016/j.bcp.2010.07.005. Epub 2010 Jul 15.

10.

Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.

Bardell TK, Barker EL.

Neurochem Int. 2010 Aug;57(1):76-83. doi: 10.1016/j.neuint.2010.05.002. Epub 2010 May 11.

11.

Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide).

Placzek EA, Cooper BR, Placzek AT, Chester JA, Davisson VJ, Barker EL.

J Pharm Biomed Anal. 2010 Nov 2;53(3):567-75. doi: 10.1016/j.jpba.2010.03.035. Epub 2010 Apr 1.

12.

Structural analysis of the extracellular entrance to the serotonin transporter permeation pathway.

Torres-Altoro MI, Kuntz CP, Nichols DE, Barker EL.

J Biol Chem. 2010 May 14;285(20):15369-79. doi: 10.1074/jbc.M109.088138. Epub 2010 Mar 19.

13.

Organized trafficking of anandamide and related lipids.

Yates ML, Barker EL.

Vitam Horm. 2009;81:25-53. doi: 10.1016/S0083-6729(09)81002-9. Review.

PMID:
19647107
14.

Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol.

Yates ML, Barker EL.

Mol Pharmacol. 2009 Jul;76(1):11-7. doi: 10.1124/mol.109.055251. Epub 2009 Apr 23. Review.

15.

Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol.

Placzek EA, Okamoto Y, Ueda N, Barker EL.

J Neurochem. 2008 Nov;107(4):987-1000. doi: 10.1111/j.1471-4159.2008.05659.x. Epub 2008 Sep 6.

16.

Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.

Placzek EA, Okamoto Y, Ueda N, Barker EL.

Neuropharmacology. 2008 Dec;55(7):1095-104. doi: 10.1016/j.neuropharm.2008.07.047. Epub 2008 Aug 8. Review.

17.

Helix XI contributes to the entrance of the serotonin transporter permeation pathway.

Torres-Altoro MI, White KJ, Rodríguez GJ, Nichols DE, Barker EL.

Protein Sci. 2008 Oct;17(10):1761-70. doi: 10.1110/ps.036749.108. Epub 2008 Jul 15.

18.

RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.

McFarland MJ, Bardell TK, Yates ML, Placzek EA, Barker EL.

Mol Pharmacol. 2008 Jul;74(1):101-8. doi: 10.1124/mol.108.044834. Epub 2008 Apr 24.

19.

Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition.

Walline CC, Nichols DE, Carroll FI, Barker EL.

J Pharmacol Exp Ther. 2008 Jun;325(3):791-800. doi: 10.1124/jpet.108.136200. Epub 2008 Mar 19.

20.

1-Methylpyridinium-4-(4-phenylmethanethiosulfonate) iodide, MTS-MPP+, a novel scanning cysteine accessibility method (SCAM) reagent for monoamine transporter studies.

Gallardo-Godoy A, Torres-Altoro MI, White KJ, Barker EL, Nichols DE.

Bioorg Med Chem. 2007 Jan 1;15(1):305-11. Epub 2006 Sep 29.

21.
22.

Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.

McFarland MJ, Terebova EA, Barker EL.

AAPS J. 2006 Mar 10;8(1):E95-100. Review.

23.

Serotonin transporters: implications for antidepressant drug development.

White KJ, Walline CC, Barker EL.

AAPS J. 2005 Oct 5;7(2):E421-33. Review.

24.

Lipid rafts: a nexus for endocannabinoid signaling?

McFarland MJ, Barker EL.

Life Sci. 2005 Aug 19;77(14):1640-50. Review.

PMID:
15978630
25.

Anandamide transport.

McFarland MJ, Barker EL.

Pharmacol Ther. 2004 Nov;104(2):117-35. Review.

PMID:
15518883
26.

A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide.

McFarland MJ, Porter AC, Rakhshan FR, Rawat DS, Gibbs RA, Barker EL.

J Biol Chem. 2004 Oct 1;279(40):41991-7. Epub 2004 Aug 3.

27.
28.

D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.

Jarrahian A, Watts VJ, Barker EL.

J Pharmacol Exp Ther. 2004 Mar;308(3):880-6. Epub 2003 Nov 21.

29.

Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis.

Roman DL, Walline CC, Rodriguez GJ, Barker EL.

Eur J Pharmacol. 2003 Oct 31;479(1-3):53-63.

PMID:
14612137
30.

Distinct molecular recognition of psychostimulants by human and Drosophila serotonin transporters.

Roman DL, Saldaña SN, Nichols DE, Carroll FI, Barker EL.

J Pharmacol Exp Ther. 2004 Feb;308(2):679-87. Epub 2003 Oct 30.

31.

Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor.

Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, Van Breemen RB, Farnsworth NR, Bolton JL.

J Agric Food Chem. 2003 Sep 10;51(19):5661-70.

PMID:
12952416
32.

Distinct recognition of substrates by the human and Drosophila serotonin transporters.

Rodríguez GJ, Roman DL, White KJ, Nichols DE, Barker EL.

J Pharmacol Exp Ther. 2003 Jul;306(1):338-46. Epub 2003 Apr 7.

33.

Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.

Kurrasch-Orbaugh DM, Watts VJ, Barker EL, Nichols DE.

J Pharmacol Exp Ther. 2003 Jan;304(1):229-37.

34.

Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.

Day TA, Rakhshan F, Deutsch DG, Barker EL.

Mol Pharmacol. 2001 Jun;59(6):1369-75.

36.

Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.

Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE.

J Med Chem. 2000 Nov 30;43(24):4701-10.

PMID:
11101361
37.

Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.

Rakhshan F, Day TA, Blakely RD, Barker EL.

J Pharmacol Exp Ther. 2000 Mar;292(3):960-7.

38.

Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter.

Barker EL, Moore KR, Rakhshan F, Blakely RD.

J Neurosci. 1999 Jun 15;19(12):4705-17.

39.

Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter.

Barker EL, Blakely RD.

Methods Enzymol. 1998;296:475-98. No abstract available.

PMID:
9779469
41.

Voltammetric approaches to kinetics and mechanism of the norepinephrine transporter.

Justice JB, Danek KS, Kable JW, Barker EL, Blakely RD.

Adv Pharmacol. 1998;42:191-4. No abstract available.

PMID:
9327876
43.

Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.

Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush E.

Mol Pharmacol. 1996 Oct;50(4):799-807.

PMID:
8863824
44.

Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.

Barker EL, Kimmel HL, Blakely RD.

Mol Pharmacol. 1994 Nov;46(5):799-807.

PMID:
7969065
45.

Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster.

Demchyshyn LL, Pristupa ZB, Sugamori KS, Barker EL, Blakely RD, Wolfgang WJ, Forte MA, Niznik HB.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):5158-62.

46.

Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.

Barker EL, Westphal RS, Schmidt D, Sanders-Bush E.

J Biol Chem. 1994 Apr 22;269(16):11687-90.

48.

Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexus.

Barker EL, Burris KD, Sanders-Bush E.

Brain Res. 1991 Jun 28;552(2):330-2.

PMID:
1655172
49.

Neuroscience nursing elective for senior nursing students.

Barker EL.

J Neurosurg Nurs. 1985 Oct;17(5):321-6.

PMID:
3850933
50.

Increased lead burden in children of battery workers: asymptomatic exposure resulting from contaminated work clothing.

Dolcourt JL, Hamrick HJ, O'Tuama LA, Wooten J, Barker EL Jr.

Pediatrics. 1978 Oct;62(4):563-6.

PMID:
714588

Supplemental Content

Loading ...
Support Center